0001209191-22-053693.txt : 20221014 0001209191-22-053693.hdr.sgml : 20221014 20221014182653 ACCESSION NUMBER: 0001209191-22-053693 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160110 FILED AS OF DATE: 20221014 DATE AS OF CHANGE: 20221014 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yen Kristen CENTRAL INDEX KEY: 0001643441 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36593 FILM NUMBER: 221312209 MAIL ADDRESS: STREET 1: 3 TWIN DOLPHIN DRIVE STREET 2: SUITE 160 CITY: REDWOOD CITY STATE: CA ZIP: 94065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLENO THERAPEUTICS INC CENTRAL INDEX KEY: 0001484565 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 770523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 203 REDWOOD SHORES PARKWAY STREET 2: SUITE 500 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 650-213-8444 MAIL ADDRESS: STREET 1: 203 REDWOOD SHORES PARKWAY STREET 2: SUITE 500 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: Capnia, Inc. DATE OF NAME CHANGE: 20100219 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-01-10 0 0001484565 SOLENO THERAPEUTICS INC SLNO 0001643441 Yen Kristen 203 REDWOOD SHORES PKWY, STE 500 REDWOOD CITY CA 94065 0 1 0 0 See Remarks Employee stock option (right to buy) 120.75 2016-01-10 4 A 0 666 0.00 A 2026-01-10 Common Stock 666 666 D Employee stock option (right to buy) 44.25 2017-04-19 4 A 0 1741 0.00 A 2027-04-19 Common Stock 1741 1741 D Employee stock option (right to buy) 24.00 2018-02-07 4 A 0 5000 0.00 A 2028-02-07 Common Stock 5000 5000 D The per share exercise price and number of shares subject to the option reflect the 1-for-5 reverse stock split effected October 15, 2017 and the 1-for-15 reverse stock split effected August 26, 2022. One forty-eighth (1/48) of the shares subject to the Option shall vest on the first month anniversary of January 10, 2016 (the "Vesting Commencement Date"), and one forty-eighth (1/48) of the total number of shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date, such that all of the shares subject to the Option will have vested as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person continuing to be a Service Provider through each such date. Twenty-five percent (25%) of the shares subject to the Option shall vest on April 19, 2017 (the "Grant Date") and one forty-eighth (1/48) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Grant Date, such that all of the shares subject to the Option will have vested as of the fourth anniversary of the Grant Date, subject to the Reporting Person continuing to be a Service Provider through each such date. The per share exercise price and number of shares subject to the option reflect the 1-for-15 reverse stock split effected August 26, 2022. One forty-eighth (1/48) of the shares subject to the Option shall vest on the first month anniversary of February 7, 2018 (the "Vesting Commencement Date"), and one forty-eighth (1/48) of the total number of shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date, such that all of the shares subject to the Option will have vested as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person continuing to be a Service Provider through each such date. Officer title: Vice President, Clinical Operations /s/ Anish Bhatnagar, Attorney-in-Fact 2022-10-14